PeptiDream Inc. (TYO: 4587)

Market Cap	331.29B
Revenue (ttm)	47.77B
Net Income (ttm)	17.11B
Shares Out	129.61M
EPS (ttm)	131.87
PE Ratio	19.38
Forward PE	27.50
Dividend	n/a
Ex-Dividend Date	n/a

Volume	518,200
Open	2,539.50
Previous Close	2,556.00
Day's Range	2,503.00 - 2,587.00
52-Week Range	1,162.00 - 3,060.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 13, 2024

About PeptiDream

PeptiDream Inc., a biopharmaceutical company, engages in the discovery and development of constrained peptides, small molecules, and peptide-drug conjugate therapeutics. The company develops its products based on its Peptide Discovery Platform System, a drug finding platform that enables the production of non-standard peptide libraries for the identification of potent and selective macrocyclic peptide candidates, which then can be developed into peptide-based, small molecule-based, peptide-drug conjugate, and multi-functional peptide conjugates...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2006
• Employees: 603
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 4587

Financial Performance

In 2023, PeptiDream's revenue was 28.71 billion, an increase of 6.93% compared to the previous year's 26.85 billion. Earnings were 3.04 billion, a decrease of -59.82%.